Medical Research Future Fund (MRFF) - Congenital Heart Disease

At a glance

Closed

Provides researchers with funding of up to $10 million to provide new diagnoses and treatment options for those suffering from congenital heart disease.

Who can apply

At a minimum, you must:

  • have an Australian Business Number (ABN)
  • be incorporated in Australia

and be one of the following eligible bodies:

  • a medical research institute
  • a university
  • a corporate Commonwealth entity
  • a corporation (including businesses and not for profits).

Other eligibility criteria apply and joint applications are encouraged.

Contact information:

13 28 46

business.gov.au/contact

Overview

Program Delegate determination made 15 July 2019:

  1. Salary on-costs are considered eligible expenditure for this grant opportunity, specifically:
    1. employer paid superannuation
    2. payroll tax
    3. workers compensation insurance.

    Salary on-costs should be reasonable and be identified in the project budget submitted with the application.

  2. Administrative overheads are not eligible expenditure for this grant opportunity.

The Congenital Heart Disease (CHD) grant opportunity forms part of the Accelerated Research initiative, funded through the Medical Research Future Fund (MRFF).

The CHD grant opportunity supports research to provide new diagnoses and treatment options for those suffering from congenital heart disease.

For this grant opportunity $20 million is available over 5 years from 2019-20 to 2023-24.

  • There is no minimum grant amount.
  • The maximum grant amount is $10 million.
  • The grant amount will be up to 100 per cent of eligible project costs.
  • You must complete your project by 30 June 2024.

Ideally projects will align with  the National Strategic Action Plan for Childhood Heart Disease, and could target the Research Priorities in the Action Plan in particular:

  • preventing neurodevelopmental and mental health complications
  • understanding the impact of prenatal and postnatal factors affecting the health of children born with CHD and their families, or
  • exploring the role of exercise and increased activity in reducing the impact of CHD.

You must ensure new research is complementary to, and does not duplicate work in the following MRFF Accelerated Research Investments:

  • The Stem Cells Australia research study into development of human heart tissue for understanding heart disease, improving repair and reconstructing tissues for kids with heart defects.
  • The Murdoch Children’s Research Institute project to enable the Australian Genomics Health Alliance to extend the Cardiovascular Genetic Disorders Flagship study, which aims to interrogate the genomic basis of disease in individuals and families with cardiomyopathies, arrhythmias and congenital heart disease.

Eligibility criteria

To be eligible you must:

  • have an Australian Business Number (ABN)
  • be incorporated in Australia
  • and, in accordance with s24 of the Medical Research Future Fund Act 2015, you must be one of the following eligible bodies:
    • a medical research institute
    • a university
    • a corporate Commonwealth entity
    • a corporation (including businesses and not for profits).

Joint applications are encouraged, provided you have a lead applicant who is the main driver of the project and is eligible to apply. For further information on joint applications, refer to the grant opportunity guidelines.

You are not eligible to apply if you are:

  • an individual
  • partnership
  • trust (however, an incorporated trustee may apply on behalf of a trust)
  • a non-corporate Commonwealth entity.

Merit criteria

To be competitive you must score highly against all of the merit criteria.

  • Merit criterion 1 Scientific quality (30 points)
  • Merit criterion 2 Significance of the expected outcomes (30 points)
  • Merit criterion 3 Your capacity, capability and resources to deliver the project (30 points)
  • Merit criterion 4 Impact of grant funding (10 points)

How to apply

The Medical Research Future Fund (MRFF) - Congenital Heart Disease grant opportunity is currently closed to applications.

How we assess applications

We assess your application against the eligibility criteria and then against the merit criteria. Only eligible applications will proceed to the merit assessment stage.

We refer your application to an independent peer review committee.

The committee will assess your application against the merit criteria and compare it to other eligible applications before recommending which projects to fund.

The amount of detail and supporting evidence you provide in your application should be relative to the project size, complexity and grant amount requested. You should define, quantify and provide evidence to support your answers.

The program delegate will make the final decision.

If your application is successful

If your application is successful, you will receive a written offer. If you are unsuccessful, we will notify you in writing and give you the chance to discuss the outcome with us.

Successful applicants must enter into a grant agreement with the Commonwealth. The grant agreement will specify the reporting requirements, payment schedule and milestones necessary to receive payments.

We will make the first payment when the grant agreement is executed. We will make subsequent payments six monthly as you achieve agreed milestones and adjusted for unspent amounts from previous payments. Payments are subject to satisfactory progress on the project.

We set aside a minimum of five per cent of the total grant funding for the final payment. We will pay this when you submit a satisfactory final report.

Payments will be made by direct credit into a nominated bank account.

Key documents

  • Grant opportunity guidelines
  • Sample application form
  • Sample grant agreement - standard  
  • Sample board or CEO approval letter

Thanks for your feedback. If you have any ideas on how we can improve, we'd love to hear them.

Please provide your comments in the feedback form.

You might also be interested in